Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.675
-0.115-1.99%
Volume:33.20M
Turnover:189.08M
Market Cap:106.03B
PE:37.34
High:5.825
Open:5.800
Low:5.650
Close:5.790
52wk High:8.335
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.61
T/O Rate:0.18%
Dividend:0.12
Dividend Rate:2.11%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.78
PE(LYR):37.34
PS:2.69

Loading ...

SBP GROUP Releases 2026 Interim Report Online and Opens Printed-Copy Requests for Non-Registered Shareholders

Bulletin Express
·
Sep 24

SBP Group Publishes 2026 Interim Report Online and Seeks Wider Adoption of E-Communication

Bulletin Express
·
Sep 24

Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong

Dow Jones
·
Sep 24

Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 22

Market Chatter: US Considers Rules Allowing American Investment in Chinese Drugs

MT Newswires Live
·
Sep 21

Hong Kong Equities Close Higher | Hang Seng Index Regains 25,000 Mark, Innovative Drug Shares Rally Broadly, SBP Group Tops Blue-Chip Gainers

Stock News
·
Sep 21

Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 21

Hang Seng Index Rallies into the Close, up More Than 1%, Testing the 25,000 Level

Tiger Newspress
·
Sep 21

Hong Kong Stock Movers | SBP Group Surges Over 6% as Management Reaffirms Annual Revenue Target, with Newly Approved Innovative Drugs Set to Drive Sustained Sales Growth

Stock News
·
Sep 21

Movement Alert|SBP GROUP Rises 3.11% in Regular Trading, Management Reaffirms Double-Digit Revenue Growth Guidance with Buy Rating from Daiwa

Market Focus
·
Sep 21

Daiwa Reaffirms Buy Rating on SBP Group After Management Reiterates Double-Digit Revenue Growth Target for the Year

Deep News
·
Sep 20

Daiwa Highlights SBP Group's Reaffirmed Double-Digit Revenue Growth Target for This Year, Retains "Buy" Rating

Stock News
·
Sep 18

Movement Alert|SBP GROUP Rises 3.18% in Regular Trading, Dual NDA Acceptances and CT Tianqing Stake Increase Completion Fuel Gains

Market Focus
·
Sep 18

Hong Kong Stocks in Focus: SBP Group Jumps Nearly 3% on Double New Drug Approval Submissions

Stock News
·
Sep 16

Sino Biopharmaceutical Says China's CDE Accepts NDA for Tqh2722 Injection

Reuters
·
Sep 16

Hong Kong Market Open: Hang Seng Index Rises 0.50% as Optics Stocks Rally, CATL Slides Over 2%

Stock News
·
Sep 16

Chinese Regulator Accepts NDA for Sino Biopharm's Breast Cancer Drug

MT Newswires Live
·
Sep 16

Sino Biopharm (SBP Group) Receives CDE Acceptance of NDA for IL-4Rα Monoclonal Antibody TQH2722 Targeting Moderate-to-Severe Atopic Dermatitis

Bulletin Express
·
Sep 16

China Biopharmaceuticals Advances Novel HER2-Targeting Bispecific ADC Toward Market Approval

Stock News
·
Sep 16

Sino Biopharmaceutical - China Cde Accepts New Drug Application for Tqb2102 Injection

THOMSON REUTERS
·
Sep 16